Vaxart, Inc. Form 4 (May 6, 2021)

Summary

Wouter Latour, a director of Vaxart, Inc., reports in this Form 4 option exercises and sales on consecutive days. On 05/06/2021 the reporting person exercised a stock option (right to buy) for 100,000 shares at $1.7 and sold 100,000 shares at $6.5389; on 05/07/2021 another 100,000 shares were exercised at $1.7 and sold at $7.1275. Options on 700,000 shares, expiring 03/23/2030, remained. A footnote states that 31.25% of the option vested on June 8, 2020 and the remaining 68.75% vests in 22 equal monthly installments, fully by April 1, 2022. Margaret Echerd signed as Attorney-in-Fact on 05/10/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Latour Wouter (Last) (First) (Middle) C/O VAXART, INC. 170 HARBOR WAY, SUITE 300 (Street) SOUTH SAN FRANCISCO CA 94080 (City) (State) (Zip) | Latour Wouter | (Last) | (First) | (Middle) | C/O VAXART, INC. | 170 HARBOR WAY, SUITE 300 | SOUTH SAN FRANCISCO | CA | 94080 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Vaxart, Inc. [ VXRT ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 05/06/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 05/06/2021 | M | 100,000 | A | $ 1.7 | 100,000 | D
Common Stock | 05/06/2021 | S | 100,000 | D | $ 6.5389 | 0 | D
Common Stock | 05/07/2021 | M | 100,000 | A | $ 1.7 | 100,000 | D
Common Stock | 05/07/2021 | S | 100,000 | D | $ 7.1275 | 0 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Stock Option (right to buy) | $ 1.7 | 05/06/2021 | M | 100,000 | (1) | 03/23/2030 | Common stock | 100,000 | $ 0 | 800,000 | D
Stock Option (right to buy) | $ 1.7 | 05/07/2021 | M | 100,000 | (1) | 03/23/2030 | Common stock | 100,000 | $ 0 | 700,000 | D
Explanation of Responses:
1. 31.25% of the shares subject to this stock option vested on June 8, 2020, the grant date, with the remaining 68.75% vesting in 22 equal monthly installments on the first day of each calendar month thereafter, such that the option shall be fully vested on April 1, 2022.
/s/ Margaret Echerd, Attorney-in-Fact for Wouter Latour | 05/10/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_VXRT_4_filed2021-05-10_0001437749-21-011553.xml

Size

18,980 bytes

SHA-256

33e5477189a73bcb6f21b864750095b5a0d4780ed41e822c1b71c5c38d1a6a6c

Our copy

SEC_VXRT_4_filed2021-05-10_0001437749-21-011553.xml

Original

www.sec.gov